Long COVID, also known as post-acute sequelae of SARS-CoV-2 infection (PASC), has become a concerning issue for many who suffer from lingering symptoms long after their initial infection has cleared.
Three patients in the UK have received a”groundbreaking” treatment for lupus on the NHS, which experts hope could eradicate the need for lifelong drugs. Until now, CAR T-cell therapy in the UK has ...